Assignee
BETAGENON AB
SE·3 granted patents·4 pending applications·3 citations·filing 2001–2024
Top patents by PatentIndex Score
7 records- 0193US11691954B2FormulationsBETAGENON AB·Filed 2022·Granted Jul 4, 2023·2 cites·47 claims
- 0291US12162850B2FormulationsBETAGENON AB·Filed 2023·Granted Dec 10, 2024·1 cites·33 claims
- 0379US2025289791A1FormulationsBETAGENON AB·Filed 2024·Application pending·0 cites
- 0458US2025136563A1Thiadiazolone derivatives useful as ampk activatorBETAGENON AB·Filed 2022·Application pending·0 cites
- 0557US2024082222A14-chloro-n-[2-[(4-chlorophenyl)methyl]-3-oxo-1,2,4-thiadiazol-5-yl]benzamide for use in medicineBETAGENON AB·Filed 2022·Application pending·0 cites
- 0638US2011177046A1Dithiazolidine and thiazolidine derivatives as anticancer agentsBETAGENON AB·Filed 2008·Application pending·0 cites
- 0729US7098375B2Animal and cell models for type II diabetes and their useBETAGENON AB·Filed 2001·Granted Aug 29, 2006·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when BETAGENON AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →